An intelligent gradient-guided hybrid inpainting framework for brain MRI reconstruction and Alzheimer's disease classification in connected healthcare systems - Top-Institutions - MDSpire

An intelligent gradient-guided hybrid inpainting framework for brain MRI reconstruction and Alzheimer's disease classification in connected healthcare systems

  • By

  • Chhaya Yadav

  • Sunita Yadav

  • Arvind Panwar

  • Massimo Donelli

  • Achin Jain

  • June 9, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Radiology
    • Neuroscience

  • #2

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, California

    Key Differentiators

    • Radiology
    • Neurology

  • #3

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, Pennsylvania

    Key Differentiators

    • Radiology
    • Neurology

  • #4

    Department of Neurology, University of Ulm
    Department of Neurology, University of Ulm

    Ulm, Baden-Württemberg

    Key Differentiators

    • Neurology
    • Radiology

  • #5

    Alzheimer’s Disease Neuroimaging Initiative
    Alzheimer’s Disease Neuroimaging Initiative

    N/A, N/A

    Key Differentiators

    • Neuroscience
    • Radiology

Original Source(s)

An intelligent gradient-guided hybrid inpainting framework for brain MRI reconstruction and Alzheimer's disease classification in connected healthcare systems

  • by Chhaya Yadav, Sunita Yadav, Arvind Panwar, Massimo Donelli, Achin Jain

  • June 9, 2026

Related Content

Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration

This Week’s CGT News: CAR-T Breaks New Ground in Alzheimer’s

First CAR-T approach for Alzheimer’s reduces amyloid plaques in mice, while cell and gene therapies advance across blood cancers, retinal disease, amyloidosis, and FSHD

  • May 11, 2026

  • 7 min
Advancing Alzheimer Disease Prediction With Large Language Model–Based Linguistic Feature Analysis: Development and Validation Study